NASDAQ NMS - GLOBAL MARKET · BFRI

+8.84% · +$0.0800 · Vol 275.2K

Market closed · last close 4:00 PM ET · price as of 17:41:26 ET

Biofrontera Inc

Pharmaceuticals

$1.00

Card

Relationship Map

Follow $BFRI

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $BFRI by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measured

Stale score · Wed Oct 7 · completed session · 2d 3h old · Scheduled each trading day · Markets closed · resumes Mon 9:30 ET · BFRI

Methodology

Fri Oct 9 snapshot unavailable for BFRI. Cause unavailable.

BFRI

Biofrontera Inc

Stale score · Wed Oct 7 · completed session · 2d 3h old · Scheduled each trading day · Markets closed · resumes Mon 9:30 ET

70/100

Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

70/ 100

Veridion Score

Upper range · HIGH confidence · 6 of 6 factors measured

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: HIGH · 6 of 6 factors measured · Stale score · Wed Oct 7 · completed session · 2d 3h old · Scheduled each trading day · Markets closed · resumes Mon 9:30 ET

Share on X →

Veridion Score History · 90D

AI Analysis

Sovereign

Why is BFRI moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move BFRI next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Oct 7
Score
Score moved +8
62/Upper range -> 70/Upper range
Veridion score historySource

About Biofrontera Inc

PHARMACEUTICAL PREPARATIONS

Listed since

2021

Employees

Country

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$0.9250

Day high

$1.01

Day low

$0.9098

Previous close

$0.9188

52W high

$1.61

-37.89% from high

52W low

$0.5700

41% of range

Market cap

$13.6M

EPS

$-0.5869

Beta

1.06

Shares out

14.9M

Volume

275.2K

0.43× rel vol

Avg volume

638.9K

VWAP

$0.9595

Price history computed in-house

-1.48%

-31.51%

-9.09%

+4.17%

YTD

+75.44%

SMA 50 $1.29 · below

SMA 200 $1.03 · below

52W position 41%

BFRI overview

Veridion Score

Registered · 2026-10-07

6 of 6 factors measured

Latest receipt rows

No recent disclosure on file.

13F holders

None on file

Relationship mapTrace receipt-backed holders and filings around BFRI.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.

SEC Form 4 ledger

BFRI insider activity

Biofrontera Inc

90 days, by filing date. Snapshot as of 2026-10-08T23:29:28.642Z.

Score

Not evaluated

Pressure

Not evaluated

Transactions

Unavailable

Filings

Unavailable

Buys / sells

Unavailable

Net value

Not evaluated

Insiders

Unavailable

Cluster

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked

Net pressure

Not evaluated: no value-bearing Form 4 rows are loaded.

Convergence not evaluated

No value-bearing Form 4 rows are loaded, so cross-source convergence is not evaluated.

Form 4 evidence state

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Public disclosures

Congress activity in BFRI

Congress tracker Open ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

BFRI contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for BFRI in this window.

Lobbying spend

BFRI lobbying filings, year to date.

Registered lobbying filings matched to Biofrontera Inc.

Not disclosed

Refresh interval: 12hSource: LDA disclosure filings

No lobbying filings on file for BFRI in this window.

Analyst ratings

Sovereign unlock shows live analyst consensus for BFRI.

Options

Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.

Related tickers

Cross-references from this score page.

Apprentice · 1 rail

Similar headline score

Nearest public composite scores. Factor similarity requires Sovereign.

Methodology

No related ticker met the data requirements for this rail.

Follow $BFRI

Why is BFRI moving today?

What can move BFRI next.

BFRI overview

Related filings and maps

BFRI insider activity

BFRI contract awards, year to date.

BFRI lobbying filings, year to date.

Cross-references from this score page.

What can move BFRI next.

BFRI insider activity

Cross-references from this score page.